Revolution Medicines Officer Jeff Cislini Files Form 144 for $666K Common Stock Sale
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Form 144 Filing Alert: Revolution Medicines, Inc. ($RVMD) š¤ Insider: Jeff Cislini (Officer) š Proposed Sale: 3,272 Common Stock shares (~$666,735.44) š Approx. Sale Date: 2026-09-15 š Acquisition: RSU vesting on 2026-09-15 š Trading Plan: Rule 10b5-1 adopted on 2023-05-31 š¦ Broker: ETRADE Financial Corporation
Comprehensive Analysis
Executive Summary
On September 15, 2026, Jeff Cislini, an Officer at Revolution Medicines, Inc. ($RVMD), submitted a Form 144 notice of proposed sale covering 3,272 shares of Common Stock with an estimated aggregate market value of $666,735.44 (approx. $203.77 per share).
Key Transaction Highlights
- Securities to be Sold: 3,272 Common Stock shares acquired via RSU vesting on September 15, 2026.
- Broker: ETRADE Financial Corporation.
- Rule 10b5-1 Plan: The proposed transaction is executed under a pre-established trading plan adopted on May 31, 2023.
- Recent Past Sales (Past 3 Months):
- August 21, 2026: 56,894 shares for gross proceeds of $11,904,246.84.
- June 16, 2026: 2,157 shares for gross proceeds of $336,748.90.
Market & Governance Impact
- Market Impact: Low. The 3,272 shares represent a negligible fraction of the company's 214,336,418 shares outstanding.
- Significance: Routine equity incentive monetization via a long-standing Rule 10b5-1 plan following RSU vesting.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.